These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3874558)

  • 1. Corticotropin-releasing factor, sauvagine, and urotensin I: effects on blood flow.
    Lenz HJ; Fisher LA; Vale WW; Brown MR
    Am J Physiol; 1985 Jul; 249(1 Pt 2):R85-90. PubMed ID: 3874558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amunine (ovine CRF), urotensin I and sauvagine, three structurally-related peptides, produce selective dilation of the mesenteric circulation.
    MacCannell KL; Lederis K; Hamilton PL; Rivier J
    Pharmacology; 1982; 25(2):116-20. PubMed ID: 6982480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the biologic actions of corticotropin-releasing factor and sauvagine.
    Brown MR; Fisher LA; Spiess J; Rivier J; Rivier C; Vale W
    Regul Pept; 1982 Jul; 4(2):107-14. PubMed ID: 6289384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRF-like effects of sauvagine and urotensin I on synaptosomal tyrosine hydroxylase activity of mouse striatum.
    Onali P; Olianas MC
    Brain Res; 1990 Sep; 526(2):181-5. PubMed ID: 1979515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin releasing factor-like peptides produce selective dilatation of the dog mesenteric circulation.
    MacCannell KL; Hamilton PL; Lederis K; Newton CA; Rivier J
    Gastroenterology; 1984 Jul; 87(1):94-102. PubMed ID: 6327456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of corticotropin releasing factor and sauvagine on social behavior of isolated mice.
    Mele A; Cabib S; Oliverio A; Melchiorri P; Puglisi-Allegra S
    Peptides; 1987; 8(5):935-8. PubMed ID: 3501578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central hyperventilatory action of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss.
    Le Mével JC; Lancien F; Mimassi N; Conlon JM
    Gen Comp Endocrinol; 2009 Oct; 164(1):51-60. PubMed ID: 19341734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular actions of the stress-related neurohormonal peptides, corticotropin-releasing factor and urotensin-I in the trout Oncorhynchus mykiss.
    Le Mével JC; Mimassi N; Lancien F; Mabin D; Conlon JM
    Gen Comp Endocrinol; 2006 Mar; 146(1):56-61. PubMed ID: 16386738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of selective mesenteric vasodilator peptides in experimental nonocclusive mesenteric ischemia in the dog.
    MacCannell KL; Newton CA; Lederis K; Rivier J; Tiffany M
    Gastroenterology; 1986 Mar; 90(3):669-76. PubMed ID: 3484710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system effects of corticotropin releasing factor in the dog.
    Brown MR; Fisher LA
    Brain Res; 1983 Nov; 280(1):75-9. PubMed ID: 6606481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRF initiates biological actions within the brain that are observed in response to stress.
    Lenz HJ; Raedler A; Greten H; Brown MR
    Am J Physiol; 1987 Jan; 252(1 Pt 2):R34-9. PubMed ID: 3544874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic and extrahypothalamic sauvagine-like immunoreactivity in the bullfrog (Rana catesbeiana) central nervous system.
    Gonzalez GC; Bountzioukas S; Gonzalez ES; McMaster D; Ko D; Lederis K; Lukowiak K
    J Comp Neurol; 1996 Feb; 365(2):256-67. PubMed ID: 8822168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats.
    Overton JM; Fisher LA
    J Auton Nerv Syst; 1991 Jul; 35(1):43-51. PubMed ID: 1940026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urotensin I-like immunoreactivity in the central nervous system of Aplysia californica.
    Gonzalez GC; Martinez-Padron M; Ko D; Lukowiak K; Lederis K
    Peptides; 1991; 12(4):787-93. PubMed ID: 1788142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol inhibits the ACTH-releasing activity of urotensin I, CRF and sauvagine observed with superfused goldfish pituitary cells.
    Fryer J; Lederis K; Rivier J
    Peptides; 1984; 5(5):925-30. PubMed ID: 6095221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of corticotropin releasing factor and sauvagine on food intake.
    Gosnell BA; Morley JE; Levine AS
    Pharmacol Biochem Behav; 1983 Nov; 19(5):771-5. PubMed ID: 6359178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cortisol and catecholamine responses to intracerebroventricular administration of CRF to rhesus monkeys.
    Insel TR; Aloi JA; Goldstein D; Wood JH; Jimerson DC
    Life Sci; 1984 May; 34(19):1873-8. PubMed ID: 6610811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
    Martinez V; Barquist E; Rivier J; Taché Y
    Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function.
    Brown MR; Gray TS; Fisher LA
    Regul Pept; 1986 Dec; 16(3-4):321-9. PubMed ID: 3031745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sauvagine-like and corticotropin-releasing factor-like immunoreactivity in the brain of the bullfrog (Rana catesbeiana).
    Gonzalez GC; Lederis K
    Cell Tissue Res; 1988 Jul; 253(1):29-37. PubMed ID: 3262016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.